New Study Links Long COVID and ME/CFS to Muscle Damage
Research conducted by the Vrije Universiteit Amsterdam (VU) indicates that muscles in individuals with Long COVID or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) exhibit distinct differences compared to those of healthy individuals who have experienced prolonged inactivity. This study addresses previous criticism suggesting that observed muscle differences were solely due to patient inactivity. To counter this, researchers compared muscle changes in Long COVID and ME/CFS patients with those in healthy individuals subjected to sixty days of bed rest. The findings revealed that patients' muscles were less red and possessed less functional mitochondria, the "energy factories" within cells. Red muscles are associated with endurance, while white muscles fatigue more easily. This color difference, according to lead researcher Rob Wüst, is attributed to both the reduced number of mitochondria and decreased blood flow, which limits oxygen and energy supply to the muscles. While sixty days of bed rest did cause some muscle changes in healthy subjects, including initial signs of diabetes and reduced muscle size, these changes were not as pronounced as those observed in Long COVID and ME/CFS patients. This suggests that the fatigue and post-exertional malaise experienced by these patients are not solely attributable to inactivity. The exact cause of these muscle alterations remains unknown, with researchers investigating whether they are a direct result of the illness or a pre-existing predisposition. The study highlights the need for further research into potential autoimmune factors or neurological inflammation. It also acknowledges the detrimental effects of inactivity but cautions that encouraging activity may not alleviate symptoms for patients suffering from post-exertional malaise, a hallmark of ME/CFS and Long COVID that can lead to extreme exhaustion and debilitation even after minor physical or mental exertion. In the Netherlands, an estimated 400,000 to 450,000 people suffer from long-term effects of COVID-19, with 90,000 to 100,000 severely affected and over 12,000 declared (partially) disabled. Currently, there is no cure for Long COVID, ME/CFS, or similar chronic post-infectious illnesses, although some existing medications show promise for symptom management, pending further research and government funding.
This research provides a scientific basis for understanding the physiological underpinnings of Long COVID and ME/CFS, moving beyond explanations solely based on inactivity. By comparing patient muscle tissue to that of individuals undergoing induced inactivity, the study isolates specific biological markers, such as reduced mitochondrial function and altered muscle color, suggesting a disease-specific pathology. This distinction is crucial for developing targeted therapies and reframing patient experiences, mitigating the risk of invalidation due to simplistic explanations. Future research directions, including autoimmune or neurological investigations, align with a systems-level approach to understanding complex chronic illnesses. The findings underscore the limitations of current public health strategies that may overemphasize general activity without accounting for the unique challenges of post-exertional malaise, highlighting a critical trade-off between promoting general well-being and managing specific disease pathologies in the post-pandemic era.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.